Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 10, 2015 2:47 AM ET


Company Overview of eXegenics Inc.

Company Overview

As of March 27, 2007, eXegenics, Inc. was acquired by Acuity Pharmaceuticals, Inc. and Froptix Corporation in a reverse merger transaction. eXegenics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment and prevention of ophthalmic disease. The company, based on its RNA Interference technology, develops a product candidate called bevasiranib, which is a small interfering RNA (siRNA) therapeutic targeting vascular endothelial growth factor. It develops bevasiranib as an intravitreal injection for the treatment of wet age-related macular degeneration (Wet AMD), and other related ocular conditions. The company is also developing treatments...

4400 Biscayne Boulevard

Suite 900

Miami, FL 33137

United States





Key Executives for eXegenics Inc.

eXegenics Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
BASF Plant Science L.P. United States
Genus Oncology, LLC United States
CytoGenix, Inc. United States
Tissue Harvest Systems, LLC United States
Orbus Therapeutics, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact eXegenics Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at